Italy – OPEN PROCEDURE FOR THE AWARDING OF A CONTRACT RESEARCH ORGANIZATION (CRO) OF SERVICES FOR THE MANAGEMENT OF THE MULTI-CENTER RANDOMIZED CLINICAL TRIAL: “COMBOSEQ - SEQUENCE STRATEGY OF IMMUNEONCOLOGY (IO-IO) VS IO-TYROSINE KINASE INHIBITORS (TKI) FOLLOWED BY TKI INMETASTATIC RENAL CELL CARCINOMA (MRCC): A RANDOMIZED PHASE 3 STUDY MEETURO AND FICOG TRIAL”, VIA SINTEL PLATFORM
By: IRCCS FOUNDATION NATIONAL CANCER INSTITUTE📍 ItalyOpen
Key Information
| Reference | GB-766672-2026 |
|---|
| Deadline | Nov 24, 2026 12:00 AM |
|---|
| Estimated Value | €2,024,000.00 |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Italy |
|---|
| Address | MILANO, 20133, Italy |
|---|
| Published | Nov 4, 2026 |
|---|
Description
2. Procedures2.1.ProceduresTitle: OPEN PROCEDURE FOR THE REFERENCE TO A CONTRACT RESEARCH ORGANIZATION (CRO) OF SERVICES FOR THE MANAGEMENT OF THE MULTI-CENTER RANDOMIZED CLINICAL TRIAL: “COMBOSEQ - S...
Full details are available after unlocking this tender.